Abstract
Background: Cystic fibrosis (CF) is an autosomal recessive disorder caused by mutations in the CFTR gene. The most severe, ΔF508, mutation accounts for nearly 70% of CF cases worldwide. Besides ΔF508, there are other point mutations, namely G542X, G551D, R553X, N1303K, and 621+1(G→T), which are common among Caucasians. Additionally, a polyT polymorphism in intron 8 is also involved in the pathogenesis of CF. However, neither the prevalence nor the types of mutations causing CF in India are known. In this study, we aimed at estimating the frequency of the above common mutations and polymorphism in clinically suspected CF cases. We also carried out partial analysis of the CFTR gene, limited to exons 10 and 11, to identify other variations in these exons.
Methods: The multiplex amplification refractory mutation system (ARMS) test was applied for rapid simultaneous analysis of six most common CF mutations, in 100 normal and 39 elevated sweat chloride cases. The scanning of exons 10 and 11 was carried out by single-stranded conformation polymorphism/heteroduplex (SSCP/HD) analysis, followed by DNA sequencing in 50 normal and 37 elevated sweat chloride cases. A single ARMS-polymerase chain reaction assay was used to distinguish the 5T, 7T, and 9T alleles in 100 normal and 33 elevated sweat chloride cases.
Results: The multiplex ARMS analysis identified the ΔF508 mutation at an allele frequency of 24% in Indian CF cases. However, the other predominant CF mutations were found to be absent. The 7T polyT variant was observed to be the most common allele, followed by the 9T, and 5T, which was the lowest. The ΔF508 mutation was observed in all instances with the 9T variant. The SSCP/HD and DNA sequencing additionally revealed a known polymorphism (M470V, exon 10) and a known mutation [1525-1(G→A), intron 9]. The 1525-1(G→A) mutation, observed in a single 4-year-old male, is predicted to code for a class II defective CFTR protein.
Conclusion: The findings of this study suggest a difference in relative frequencies and spectrum of CFTR mutations in Indian CF cases. A larger screening study of the entire CFTR gene in clinically well defined CF cases is required to delineate common mutations in the CFTR gene and enable molecular diagnosis of CF in India.
Similar content being viewed by others
References
Sarsfield JK, Daves JM. Negative sweat tests and cystic fibrosis: archives of disease in childhood. Arch Dis Child 1975; 50: 463–6
Rosenstein BJ. What is a cystic fibrosis diagnosis? In: Fiel SB, editor. Clinics in chest medicine. Philadelphia (PA): Saunders, 1998: 423–41
Farrell PM, Koscik RE. Sweat chloride concentrations in infants homozygous and heterozygous for F508 cystic fibrosis. Pediatrics 1996; 97: 524–8
Mickle JE, Cutting GR. Clinical implications of cystic fibrosis transmembrane conductance regulator mutations. In: Fiel SB, editor. Clinics in chest medicine. Philadelphia (PA): Saunders, 1998: 443–58
Kabra M, Wallace A, Ghosh M, et al. Cystic fibrosis in India: report of 30 cases and frequency of AF508 mutation. Ind J Hum Genet 1998; 4: 103–5
Ahuja AS, Kabra SK. Cystic fibrosis: Indian experience. Indian Pediatr 2002; 39: 813–8
Singh M, Prasad R, Kumar L. Cystic fibrosis in north Indian children. Indian J Pediatr 2002; 69(7): 627–9
Ashavaid TF, Dherai AJ, Kondkar AA, et al. Molecular diagnosis of cystic fibrosis in Indian patients: a preliminary report. J Assoc Physicians India 2003; 5: 345–8
Kabra M, Ghosh M, Kabra SK, et al. AF508 molecular mutation in Indian children with cystic fibrosis. Indian J Med Res 1996; 104: 355–8
Kabra M. Is the spectrum of mutation in Indian patients with cystic fibrosis different? Am J Med Genet 2000; 93: 161–3
Kabra SK, Kabra M, Lodha R, et al. Clinical profile and frequency of ΔF508 mutation in Indian children with cystic fibrosis. Indian Pediatr 2003; 40: 612–9
Miller SK, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 19: 1215
Ferrie RM, Schwarz MJ, Robertson NH, et al. Development, multiplexing and application of ARMS test for common mutation in CFTR gene. Am J Hum Genet 1992; 51: 251–62
Liechti-Gallati S, Schneider V, Neeser D, et al. Two buffer PAGE system-based SSCP/HD analysis: a general protocol for rapid and sensitive mutation screening in cystic fibrosis and any other human genetic disease. Eur J Hum Genet 1999; 7: 590–8
Friedman KJ, Heim RA, Knowles MR. Rapid characterization of the variable length polythymidine tract in the cystic fibrosis (CFTR) gene: association of the 5T allele with selected CFTR mutations and its incidence in atypical sinopulmonary disease. Hum Mutat 1997; 10: 108–15
Cuppens H, Teng H, Raeymaekers P, et al. CFTR haplotype backgrounds on normal and mutant CFTR genes. Hum Mol Genet 1994 Apr; 3(4): 607–14
Dork T, Wulbrand U, Tummler B. Four novel cystic fibrosis mutations in splice junction sequences affecting the CFTR nucleotide binding folds. Genomics 1993; 15(3): 688–91
Ramalho AS, Beck S, Penque D, et al. Transcript analysis of the cystic fibrosis splicing mutation 1525-1(G→A) shows use of multiple alternative splicing sites and suggests a putative role of exonic splicing enhancers. J Med Genet 2003; 40(7): e88
Costes B, Girodon E, Ghanem N. Frequent occurrence of the CFTR intron 8 (TG)n5T allele in men with congenital bilateral absence of the vas deferens. Eur J Hum Genet 1995; 3: 285–93
Lissens W, Mercier B, Tournaye H, et al. Cystic fibrosis and infertility caused by congenital bilateral absence of the vas deferens and related clinical entities. Hum Reprod 1996; 11: 55–80
Acknowledgements
This study was funded by the National Health and Education Society, P.D. Hinduja National Hospital and Medical Research Centre, Mumbai, India. We thank Dr Michael Schwarz, Regional Molecular Genetics Laboratory, Manchester, UK for providing us with the mutation positive control DNA samples used in this study.
The authors have no potential conflicts of interest relevant to the contents of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ashavaid, T.F., Kondkar, A.A., Dherai, A.J. et al. Application of Multiplex ARMS and SSCP/HD Analysis in Molecular Diagnosis of Cystic Fibrosis in Indian Patients. CNS Drugs 9, 59–66 (2005). https://doi.org/10.1007/BF03260073
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03260073